In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Quotient nets $16.6mm through FOPO to fund MosaiQ commercialization

Executive Summary

Transfusion diagnostics firm Quotient Ltd. publicly sold 3.2mm common shares (including the overallotment) at $5.50 apiece for net proceeds of $16.6mm. The company will use some of the funds for development and commercialization of the MosaiQ donor and patient blood screening and characterization platform.
Deal Industry
  • In Vitro Diagnostics
  • Laboratory Testing Services
  • Research, Analytical Equipment & Supplies
  • In Vitro Diagnostics
    • Hematology, Coagulation
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies